BioCentury
ARTICLE | Clinical News

CAP-1002: Preliminary Phase I data

September 5, 2016 7:00 AM UTC

Preliminary data from 12 evaluable patients with New York Heart Association (NYHA) Class III heart failure in the open-label, dose-escalation Phase Ia portion of the U.S. Phase Ia/b DYNAMIC trial show...